In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to various quality-of-life domains.

It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol Hill purple at the 2026 National Lupus Advocacy Summit this April!

How would you treat a 30-year-old woman with systemic lupus erythematous (SLE) and lupus nephritis (LN) class 3 with new ...

In patients with active systemic lupus erythematosus unresponsive to conventional hydroxychloroquine-based therapy, adding mepacrine shows improved outcomes with few and mild side effects.

In a new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen ...

An international team, led by Paul R. Fortin of Université Laval, has just identified three markers that would allow for establishing, right at the time of diagnosis, the risk of a lupus ...

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...

Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease with a heterogeneous clinical presentation, ranging from mild cutaneous manifestations to severe organ damage. One of ...

Please provide your email address to receive an email when new articles are posted on . Early mycophenolate mofetil in newly diagnosed SLE led to fewer severe flares and lower incidence of lupus ...

The total market size of systemic lupus erythematosus is expected to increase in the 7MM during the forecast period, driven by ongoing clinical research of therapies such as nipocalimab (Johnson & ...

It's long been known that money woes tend to worsen health outcomes in people with chronic diseases. The demographics of ...